Vaginal estrogen therapy appears to be safe after early breast cancer in patients with HR-negative tumors and those with HR-positive tumors concurrently treated with tamoxifen, new data suggest.
New data presented at ESMO suggest that assisted reproductive techniques are safe for women with BRCA1/2 mutations who have been treated for breast cancer.
Study in women with high-risk genes and a pregnancy after breast cancer shows Assisted Reproductive Techniques are safe, with no increase in breast cancer recurrence.